{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:42:50Z","timestamp":1790836970958,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10147-023-02433-8","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T22:02:22Z","timestamp":1701900142000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk factors of secondary cancer in laryngeal, oropharyngeal, or hypopharyngeal cancer after definitive therapy"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9944-4474","authenticated-orcid":false,"given":"Goshi","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Oridate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"2433_CR1","unstructured":"National Cancer Center, Japan. Cancer Statistics. Accessed June 1, 2023. http:\/\/ganjoho.jp\/reg_stat\/"},{"issue":"9","key":"2433_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archotol.1984.00800350006003","volume":"110","author":"B Vikram","year":"1984","unstructured":"Vikram B (1984) Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 110(9):564\u2013565","journal-title":"Arch Otolaryngol"},{"issue":"4","key":"2433_CR3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1200\/JCO.1995.13.4.876","volume":"13","author":"EE Vokes","year":"1995","unstructured":"Vokes EE, Kies M, Haraf DJ et al (1995) Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol 13(4):876\u2013883","journal-title":"J Clin Oncol"},{"issue":"3","key":"2433_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/jnci\/89.3.199","volume":"89","author":"FR Khuri","year":"1997","unstructured":"Khuri FR, Lippman SM, Spitz MR et al (1997) Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst 89(3):199\u2013211","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2433_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.otohns.2007.12.034","volume":"138","author":"A Watanabe","year":"2008","unstructured":"Watanabe A, Taniguchi M, Tsujie H et al (2008) The value of narrow band imaging endoscope for early head and neck cancers. Otolaryngol Head Neck Surg 138(4):446\u2013451","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"9","key":"2433_CR6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00595-013-0713-3","volume":"44","author":"M Morita","year":"2014","unstructured":"Morita M, Saeki H, Ito S et al (2014) Surgical strategies for esophageal cancer associated with head and neck cancer. Surg Today 44(9):1603\u20131610","journal-title":"Surg Today"},{"issue":"1","key":"2433_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/000348940711600104","volume":"116","author":"GS Weinstein","year":"2007","unstructured":"Weinstein GS, O\u2019Malley BW Jr, Snyder W et al (2007) Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 116(1):19\u201323","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"2433_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10147-020-01779-7","volume":"26","author":"G Nishimura","year":"2021","unstructured":"Nishimura G, Sano D, Arai Y et al (2021) The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer. Int J Clin Oncol 26(1):59\u201365","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"2433_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s10147-021-02080-x","volume":"27","author":"G Nishimura","year":"2022","unstructured":"Nishimura G, Sano D, Arai Y et al (2022) A risk factor for newly diagnosed secondary cancer in patients with early-stage laryngeal, oropharyngeal, or hypopharyngeal cancer: sub-analysis of a prospective observation study. Int J Clin Oncol 27(3):488\u2013494","journal-title":"Int J Clin Oncol"},{"issue":"19","key":"2433_CR10","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa032646","volume":"350","author":"JS Cooper","year":"2004","unstructured":"Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937\u20131944","journal-title":"N Engl J Med"},{"issue":"19","key":"2433_CR11","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"J Bernier","year":"2004","unstructured":"Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945\u20131952","journal-title":"N Engl J Med"},{"issue":"1","key":"2433_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00280-017-3352-3","volume":"80","author":"G Nishimura","year":"2017","unstructured":"Nishimura G, Shiono O, Sano D et al (2017) Efficacy and safety of postoperative bio-chemoradiotherapy using cetuximab and docetaxel for high-risk head and neck cancer patients in Japan. Cancer Chemother Pharmacol 80(1):203\u2013207","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"2433_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/sj.bjc.6601471","volume":"90","author":"H Katori","year":"2004","unstructured":"Katori H, Tsukuda M, Mochimatu I et al (2004) Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of head and neck (SCCHN). Br J Cancer 90(2):348\u2013352","journal-title":"Br J Cancer"},{"issue":"4","key":"2433_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00280-009-1217-0","volume":"66","author":"M Tsukuda","year":"2010","unstructured":"Tsukuda M, Ishitoya J, Matsuda H et al (2010) Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and 25 leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 66(4):729\u2013736","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"2433_CR15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00280-016-3052-4","volume":"77","author":"G Nishimura","year":"2016","unstructured":"Nishimura G, Taguchi T, Takahashi M et al (2016) Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma. Cancer Chemother Pharmacol 77(6):1315\u20131319","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"2433_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21(1):92\u201398","journal-title":"J Clin Oncol"},{"issue":"6","key":"2433_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari P, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of head and neck. N Engl J Med 354(6):567\u2013578","journal-title":"N Engl J Med"},{"issue":"5","key":"2433_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00280-009-0946-4","volume":"64","author":"M Tsukuda","year":"2009","unstructured":"Tsukuda M, Ishitoya J, Mikami Y et al (2009) Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and\/or cases with comorbidity. Cancer Chemother Pharmacol 64(5):945\u2013952","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"2433_CR19","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00405-012-1999-2","volume":"269","author":"AM Mumme","year":"2012","unstructured":"Mumme AM, Laban S, Knecht R (2012) New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011. Wur Arch Otorhinolaryngol 269(11):2303\u20132308","journal-title":"Wur Arch Otorhinolaryngol"},{"issue":"10","key":"2433_CR20","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.3390\/cells10102585","volume":"10","author":"N Fujimoto","year":"2021","unstructured":"Fujimoto N, Dieterich LC (2021) Mechanisms and clinical significance of tumor lymphatic invasion. Cells 10(10):2585","journal-title":"Cells"},{"issue":"5","key":"2433_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/cncr.32590","volume":"126","author":"M Zaitsu","year":"2020","unstructured":"Zaitsu M, Takeuchi T, Kobayashi Y et al (2020) Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan. Cancer 126(5):1031\u20131040","journal-title":"Cancer"},{"key":"2433_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/annonc\/mdg305","volume":"14","author":"P Boyle","year":"2003","unstructured":"Boyle P, Autier P, Bartelink H et al (2003) European code against cancer and scientific justification: third version. Ann Oncol 14:973\u20131005","journal-title":"Ann Oncol"},{"key":"2433_CR23","volume-title":"Global status report on alcohol","author":"World Health Organization","year":"1999","unstructured":"World Health Organization (1999) Global status report on alcohol. World Health Organization, Geneva"},{"key":"2433_CR24","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3390\/ijms18091943","volume":"18","author":"A Mizumoto","year":"2017","unstructured":"Mizumoto A, Ohashi S, Hirohashi K et al (2017) Molecular mechanisms of acetaldehyde-mediated carcinogenesis in squamous epithelium. Int J Mol Sci 18:1943","journal-title":"Int J Mol Sci"},{"key":"2433_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1470-2045(06)70577-0","volume":"7","author":"P Boffetta","year":"2006","unstructured":"Boffetta P, Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7:149\u2013156","journal-title":"Lancet Oncol"},{"issue":"1","key":"2433_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.bjc.6602277","volume":"92","author":"M Inoue","year":"2005","unstructured":"Inoue M, Tsugane S, JPHC Study Group (2005) Impact of alcohol drinking on total cancer risk: data from a large-scale population-based cohort study in Japan. Br J Cancer 92(1):182\u2013187","journal-title":"Br J Cancer"},{"issue":"2","key":"2433_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1158\/1055-9965.EPI-08-0758","volume":"18","author":"A Yokoyama","year":"2009","unstructured":"Yokoyama A, Kumagai Y, Yokoyama T et al (2009) Health risk appraisal models for mass screening for esophageal and pharyngeal cancer: an endoscopic follow-up study of cancer-free Japanese men. Cancer Epidemiol Biomarkers Prev 18(2):651\u2013655","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2433_CR28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.4103\/jcrt.JCRT_980_17","volume":"15","author":"Y Yamashita","year":"2019","unstructured":"Yamashita Y, Ikegami T, Suzuki M et al (2019) Hypopharyngeal cancer risk in Japanese: genetic polymorphisms related to the metabolism of alcohol- and tobacco-associated carcinogens. J Cancer Res Ther 15(3):556\u2013563","journal-title":"J Cancer Res Ther"},{"issue":"5","key":"2433_CR29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11604-010-0432-2","volume":"28","author":"A Mesbahi","year":"2010","unstructured":"Mesbahi A, Seyednejad F, Gasemi-Jangjoo A (2010) Estimation of organs doses and radiation-induced secondary cancer risk from scattered photons for conventional radiation therapy of nasopharynx: a Monte Carlo study. Jpn J Radiol 28(5):398\u2013403","journal-title":"Jpn J Radiol"},{"issue":"10","key":"2433_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejmp.2017.10.021","volume":"90","author":"M Mazonakis","year":"2017","unstructured":"Mazonakis M, Damilakis J (2017) Out-of-field organ doses and associated risk of cancer development following radiation therapy with photons. Phys Med 90(10):73\u201382","journal-title":"Phys Med"},{"key":"2433_CR31","volume-title":"Health effects of exposure to low levels of ionizing radiation","author":"V Beir","year":"1990","unstructured":"Beir V (1990) Health effects of exposure to low levels of ionizing radiation. National Academies Press, Washington DC"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02433-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-023-02433-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02433-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T22:06:25Z","timestamp":1706133985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-023-02433-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2433"],"URL":"https:\/\/doi.org\/10.1007\/s10147-023-02433-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3026392\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for the study was obtained from the Yokohama City University Institutional Review Board (#F230200009). Written informed consent was obtained from the participants to publish their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patients consent for publication"}}]}}